Anti-CCL3 monoclonal antibodies strongly inhibited joint injury and bone erosion in a collagen-induced arthritis (CIA) mouse model (28); AMG487, the antagonist of CXCR3, a receptor for chemokines CXCL9–11, also supressed RA in a CIA model (29). This evidence concerns the gene CCL3 and rheumatoid arthritis.